As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

In dawn raids in four counties across the West Midlands and Northwest of England this morning, 12 suspects were arrested in ...

The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the ...

Grambley discusses how AI can be leveraged to create highly personalised patient engagement strategies, tailored to ...